A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular carcinoma (HCC) patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Mol Hepatol
Autors principals: Yang, Hyun, Woo, Hyun Young, Lee, Soon Kyu, Han, Ji Won, Jang, Bohyun, Nam, Hee Chul, Lee, Hae Lim, Lee, Sung Won, Song, Do Seon, Song, Myeong Jun, Oh, Jung Suk, Chun, Ho Jong, Jang, Jeong Won, Lozada, Angelo, Bae, Si Hyun, Choi, Jong Young, Yoon, Seung Kew
Format: Artigo
Idioma:Inglês
Publicat: The Korean Association for the Study of the Liver 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497665/
https://ncbi.nlm.nih.gov/pubmed/28494528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0071
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars